A comparison of two amikacin dosing regimens in paediatric surgical patients

Annals of Tropical Paediatrics

Volumn 17, Issue 3, 1997, Pages 253-261

  Forsyth, N B ^a   Botha, J H ^a   Hadley, G P ^a  

^a UNIVERSITY OF NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CREATININE;

ARTICLE; BODY TEMPERATURE; CHILD; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; MALE; NEPHROTOXICITY; OTOTOXICITY; PEDIATRIC SURGERY; POSTOPERATIVE INFECTION; PURE TONE AUDIOMETRY; SURGICAL PATIENT;

EID: 0030881979     PISSN: 02724936     EISSN: None     Source Type: Journal    
DOI: 10.1080/02724936.1997.11747896     Document Type: Article

References (31)

1. Prins JM, Büller HR, Kuijper EJ, Tange RA, Speelman P. Once versus thrice daily gentamicin in patients with serious infections. Lancet 1993; 341:335-9.
2. Marik PE, Lipman J, Kobilski S, Scribante J. A prospective randomized study comparing once-versus twice-daily amikacin dosing in critically ill adult and paediatric patients. J Antimicrob Chemother 1991; 28:753-64.
3. Sturm AW. Netilmicin in the treatment of Gram-negative bacteremia: single daily versus multiple daily dosage. J Infect Dis 1989; 159:931-7.
4. Barclay ML, Begg EJ, Hickling KG. What is the evidence for once-daily aminoglycoside therapy? Clin Pharmacokinet 1994; 27:32-48.
5. Vogelman B, Craig WA. Kinetics of antimicrobial activity. J Pediatr 1986; 108:835-40.
6. Moore RD, Lietman PS, Smith CR. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 1987; 155:93-9.
7. Zhanel GG, Hoban DJ, Harding GKM. The postantibiotic effect: a review of in vitro and in vivo data. DICP, Ann Pharmacother 1991; 25:153-63.
8. Craig WA, Vogelman B. The postantibiotic effect. Ann Intern Med 1987; 106:900-2.
9. De Broe ME, Verbist L, Verpooten GA. Influence of dosage schedule on renal cortical accumulation of amikacin and tobramycin in man. J Antimicrob Chemother 1991; 27(Suppl. C):41-7.
10. Mattie H, Craig WA, Pechère JC. Review. Determinants of efficacy and toxicity of aminoglycosides. J Antimicrob Chemother 1989; 24:281-93.
11. Tran Ba Huy P, Bernard P, Schacht J. Kinetics of gentamicin uptake and release in the rat. Comparison of inner ear tissues and fluids with other organs. J Clin Invest 1986; 77:1492-1500.
12. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. Ann Intern Med 1993; 119:584-93.
13. Viganò A, Principi N, Brivio L, Tommasi P, Stasi P, Dalla Villa A. Comparison of 5 milligrams of netilmicin per kilogram of body weight once daily versus 2 milligrams per kilogram thrice daily for treatment of gram-negative pyelonephritis in children. Antimicrob Agents Chemother 1992; 36:1499-1503.
14. Shankar A, Sharma SD. Gentamicin as once-daily dose therapy in recurrent urinary tract infections in children. Curr Ther Res 1987; 41:599-603.
15. Elhanan K, Siplovich L, Raz P. Gentamicin once-daily versus thrice-daily in children. J Antimicrob Chemother 1995; 35:327-32.
16. Kafetzis DA, Sianidou L, Vlachos E, et al. Clinical and pharmacokinetic study of a single daily dose of amikacin in paediatric patients with severe Gram-negative infections. J Antimicrob Chemother 1991; 27(Suppl.C): 105-12.
17. Trujillo H, Robledo J, Robledo C, et al. Single daily dose amikacin in paediatric patients with severe Gram-negative infections. J Antimicrob Chemother 1991; 27(Suppl. C):141-7.
18. Viscoli C, Dudley M, Ferrea G, et al. Serum concentrations and safety of single daily dosing of amikacin in children undergoing bone marrow transplantation. J Antimicrob Chemother 1991; 27(Suppl.C):113-20.
19. Bouffet E, Fuhrmann C, Frappaz D, et al. Once daily antibiotic regimen in paediatric oncology. Arch Dis Child 1994; 70:484-7.
20. Principi N, Gervasoni A, Reali E, Tagliabue P. Treatment of urinary tract infections in children with a single daily dose of gentamicin. Helv Paediatr Acta 1977; 32:343-50.
21. Zaske DE, Shikuma LJR, Tholl DA. Aminoglycosides. In: Taylor WJ, Diers Caviness MH, eds. A Textbook for the Clinical Application of Therapeutic Drug Monitoring. Irving, Texas: Abbott Laboratories, 1986; 285-320.
22. Kauffman RE. Drug therapeutics in the infant and child. In: Yaffe SJ, Aranda JV, eds. Pediatric Pharmacology. Therapeutic Principles in Practice. Philadelphia: Saunders, 1992; 212-19.
23. Vogelstein B, Kowarski AA, Lietman PS. The pharmacokinetics of amikacin in children. J Pediatr 1977; 91:333-9.
24. Assael BM, Rusconi F. Aminoglycoside antibiotics. In: Yaffe SJ, Aranda JV, eds. Pediatric Pharmacology. Therapeutic Principles in Practice. Philadelphia: Saunders, 1992; 244-51.
25. Rowland M, Tozer TN. Intravenous dose. In: Rowland M, Tozer TN, eds. Clinical Pharmacokinetics: Concepts and Applications. Philadelphia: Lea & Febiger, 1989; 17-32.
26. Strome M, Kelly JH, Fried MP. Ear. In: Strome M, Kelly JH, Fried MP, eds. Manual of Otolarnygology. Diagnosis and Therapy. Boston: Little, Brown, 1985; 41-86.
27. Levison ME. New dosing regimens for aminoglycoside antibiotics. Ann Intern Med 1992; 117: 693-4.
28. Garrison MW, Zaske DE, Rotschafer JC. Aminoglycosides: another perspective. DICP, Ann Pharmacother 1990; 24:267-72.
29. McLean AJ, Bastone EB, Ionnides-Demos LL, Spicer WJ. Bactericidal effect of gentamicin trough concentration provides a rationale for administration of bolus doses and maintenance of trough levels. J Antimicrob Chemother 1994; 33:999-1004.
30. Daikos GL, Jackson GG, Lolans VT, Livermore DM. Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation. J Infect Dis 1990; 162:414-20.
31. Barclay ML, Begg EJ, Chambers ST. Adaptive resistance following single doses of gentamicin in a dynamic in vitro model. Antimicrob Agents Chemother 1992; 36:1951-7.